Loading
Every funder that spends more than $50 million a year on cancer research would publish what it funds in a shared, coded database, so gaps and duplication can be seen across the whole system.
The International Cancer Research Partnership already codes members' portfolios by cancer type and Common Scientific Outline category, but participation is voluntary and misses most industry-funded academic work, Chinese funders and a large part of European funding. Governments and umbrella bodies would require reporting as a condition of charitable tax status or public co-funding, with a common ontology, award-level data and outputs linked (publications, trials, patents). Coverage is what turns a nice database into a planning tool.
Shares Burden-weighted portfolio targets for every major cancer funder, Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares A public dashboard of research money per death for every cancer, Funding follows fashion, not burden.
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Burden-weighted portfolio targets for every major cancer funder, Funding follows fashion, not burden.
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).